GOCO — GoHealth Cashflow Statement
0.000.00%
Last trade - 00:00
- $214.25m
- $794.19m
- $734.67m
- 74
- 93
- 41
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -41.1 | -97.2 | -534 | -376 | -151 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 159 | 237 | 434 | 60.1 | 38.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -151 | -352 | -306 | 270 | 116 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.003 | -114 | -299 | 60.9 | 109 |
Capital Expenditures | -8.02 | -14.5 | -19.8 | -13.5 | -13.7 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -808 | — | — | — | — |
Acquisition of Business | |||||
Cash from Investing Activities | -816 | -14.5 | -19.8 | -13.5 | -13.7 |
Financing Cash Flow Items | -9.28 | -715 | -6.62 | -4.68 | -2.29 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 827 | 261 | 259 | -115 | -21.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 11.8 | 132 | -59.9 | -67.9 | 74.3 |